[Federal Register Volume 70, Number 183 (Thursday, September 22, 2005)]
[Notices]
[Pages 55629-55630]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-18903]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Agency Information Collection Activities: Proposed Collection; 
Comments Requested

ACTION: 60-Day Emergency Notice of Information Collection Under Review: 
Application for Procurement Quota for Controlled Substances.

-----------------------------------------------------------------------

    The Department of Justice, Drug Enforcement Administration (DEA), 
has submitted the following information collection request to the 
Office of Management and Budget (OMB) for review and clearance in 
accordance with emergency review procedures of the Paperwork Reduction 
Act of 1995. OMB approval has been requested by September 30, 2005. The 
proposed information collection is published to obtain comments from 
the public and affected agencies. If granted, the emergency approval is 
only valid for 180 days. Comments should be directed to the Office of 
Management and Budget, Office of Information and Regulation Affairs, 
Attention: Department of Justice Desk Officer, Washington, DC 20503. 
Comments are encouraged and will be accepted for 60 days until November 
21, 2005.
    During the first 60 days of this same review period, a regular 
review of this information collection is also being undertaken. All 
comments and suggestions, or questions regarding additional 
information, to include obtaining a copy of the proposed information 
collection instrument with instructions, should be directed to Patricia 
M. Good, Chief, Office of Diversion Control, Drug Enforcement 
Administration, Washington, DC 20537.
    Written comments and suggestions from the public and affected 
agencies concerning the proposed collection of information are 
encouraged. Your comments should address one or more of the following 
four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agencies estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

    Overview of this information:
    (1) Type of information collection: Revision of a Currently 
Approved Collection.
    (2) The title of the form/collection: Application for procurement 
quota for controlled substances.
    (3) The agency form number, if any, and the applicable component of 
the department sponsoring the collection: Form Number: DEA Form 250. 
Office of Diversion Control, Drug Enforcement Administration, 
Department of Justice.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract: Primary: Business or other for-profit. Other: 
none. Title 21 U.S.C. 826 and 21 CFR 1303.12, require that U.S. 
companies who desire to use any basic class of controlled substances 
listed in Schedule I or II for purposes of manufacturing during the 
next calendar year shall apply on DEA Form 250 for procurement quota 
for such class.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to

[[Page 55630]]

respond: It is estimated that 255 persons submit 1,106 completed DEA 
Forms 250, at 1 hour per form, for an annual burden of 1,106 hours. It 
is estimated that 25 companies submit information pertaining to new 
drug applications or abbreviated new drug applications, at 2 hours per 
response, for an annual burden of 50 hours.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: It is estimated that the total annual burden 
associated with this information collection is 1,156 hours.
    If additional information is required contact: Brenda E. Dyer, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Patrick Henry 
Building, Suite 1600, 601 D Street NW., Washington, DC 20530, or by e-
mail at [email protected].

    Dated: September 16, 2005.
Brenda E. Dyer,
Department Clearance Officer, Department of Justice.
[FR Doc. 05-18903 Filed 9-21-05; 8:45 am]
BILLING CODE 4410-09-P